Secondary Stroke Prevention and Antiplatelet Therapy

Journal of the American College of Cardiology

Volumn 47, Issue 12, 2006, Pages 2568-

  Horton, Heather L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DIPYRIDAMOLE;

CLINICAL PRACTICE; CORONARY ARTERY THROMBOSIS; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; HIGH RISK PATIENT; HUMAN; LETTER; PRIORITY JOURNAL; RISK REDUCTION; STROKE; TRANSIENT ISCHEMIC ATTACK;

ASPIRIN; CEREBROVASCULAR ACCIDENT; DIPYRIDAMOLE; DRUG COMBINATIONS; HUMANS; PLATELET AGGREGATION INHIBITORS;

EID: 33744974491     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.03.026     Document Type: Letter

References (5)

1. Gebel J.M. Secondary stroke prevention with antiplatelet therapy with emphasis on the cardiac patient. J Am Coll Cardiol 46 (2005) 752-755
2. Diener H.C., Bogousslavsky J., Brass M., et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic or transient ischaemic attack in high-risk patients (MATCH). randomized, double-blind, placebo-controlled trial. Lancet 364 (2004) 331-337
3. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patient. BMJ 324 (2002) 71-86
4. Ridker P., Cook N.R., Lee I.M., et al. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 352 (2005) 1293-1304
5. Tran H., and Anand S.S. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. JAMA 292 (2004) 1867-1874